Methods of using mammalian RNase H and compositions thereof

Details for Australian Patent Application No. 2002253943 (hide)

Owner ISIS PHARMACEUTICALS, INC.

Inventors Wu, Hongjiang; Lima, Walter F.; Crooke, Stanley T.

Agent FB Rice

Pub. Number AU-A-2002253943

PCT Pub. Number WO2002/064841

Priority 09/781,712 12.02.01 US

Filing date 12 February 2002

Wipo publication date 28 August 2002

International Classifications

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 015/85 Mutation or genetic engineering - for animal cells

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-A-2002253943

23 November 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002253944-METHOD AND APPARATUS FOR INSITU SPECTROSCOPIC DETECTION AND ANALYSIS OF POLYMORPHIC MODIFICATIONS

2002253942-METHODS AND COMPOSITIONS FOR CONTROL OF BONE FORMATION VIA MODULATION OF CILIARY NEUROTROPHIC FACTOR ACTIVITY